Kriteriji za ocjenu sposobnosti za rad u zdravstvenih radnika inficiranih virusima hepatitisa B i C by Federica Prati et al.
19Arh Hig Rada Toksikol 2000;51:19–26
SCREENING OF HEALTH
CARE WORKERS FOR




Federica PRATI1, Vittorio LODI2,
Vincenzo D’ELIA2, Davide
TRUFFELLI1, Hrvoje LALI]1, and
Giovanni Battista RAFFI1
Unit of Occupational Medicine,
S. Orsola-Malpighi Polyclinic,
Bologna1, Italy
Unit of Safety, Hygiene and
Occupational Medicine of the
Bologna University, Bologna2, Italy
Received January 2000
SHORT COMMUNICATION
The aim of this study was to propose a protocol for
assessment of markers of infection with hepatitis
B virus (HBV) and hepatitis C virus (HCV) in
exposed health care professionals and to define
criteria for evaluation of fitness for the job of the
infected personnel. The study comprised 800
persons involved in operative procedures,
including 414 surgeons, 275 nurses, and 111
anaesthetists. A graduated protocol was created
for monitoring markers of HBV and HCV infection.
A well-defined combination of markers of antigen-
antibody systems enabled identification of four
groups of persons with HBV infection differing in
fitness for work: 1) HBsAg-positive, HBeAg-
positive, HBV DNA-positive; 2) HBsAg-positive,
anti-HBe-positive, HBV DNA-positive; 3) HBsAg-
positive, anti-HBe-positive, HBV DNA-negative;
and 4) anti-HBs-positive, anti-HBc-positive,
anti-HBe-positive group. For HCV infection, two
groups with different job fitness were identified:
1) anti-HCV-positive, HCV RNA-negative and
2) anti-HCV-positive, HCV RNA-positive.
Screening of hospital personnel at risk to HBV and
HCV infection requires a well-defined protocol
which may help to evaluate the fitness of the
infected personnel for a specific job.
Key words:
antigen-antibody system, graduated protocol,
markers of infection, occupational exposure
In the hospital environment, particularly in some wards, there is a high risk of con-
tact with biological agents. The risk of infection by hepatitis B virus (HBV) and hepa-
titis C virus (HCV) in occupationally exposed health care workers is a matter of con-
siderable concern. This is due to high prevalence of these infections in the general
population, high infection capacity of these viruses, and everyday contact with biologi-
cal liquids and potentially contaminated surgical or medical instruments (1, 2).
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Hepatitis B virus
Hepatitis B virus is the most thoroughly characterised and complex aetiologic agent.
The infective (so-called Dane) particle consists of a viral core plus an outer surface
coat (3). Surface coat can be detected in serum by immunologic means as hepatitis
B surface antigen (HBsAg, formerly Australia antigen). Its presence in serum is usually
the first evidence of acute HBV infection and implies infectivity of the blood. The
corresponding protective antibody (anti-HBs) appears after clinical recovery and usu-
ally persists for life. Other two antigen-antibody systems are associated with the viral
core of HBV. They are core antigen (HBcAg) and e antigen (HBeAg). HBcAg can be
found in infected liver cells and is not detectable in serum except by special tech-
niques that disrupt the Dane particle. Antibody to HBcAg (anti-HBc) generally ap-
pears at the onset of clinical illness and thereafter gradually diminish. It is regularly
found in chronic HBsAg carriers. In acute infection, anti-HBc is predominantly in IgM
class. The e antigen (HBeAg) can be found only in HBsAg-positive serum and it tends
to parallel the production of viral DNA polymerase. Presence of anti-HBe points to
relatively lower infectivity.
HBV has a high prevalence in the Italian population (0.5 to 5.6%) (4). It shows
strong resistance to environment and disinfection as well as high transmissibility with
a minimum dose (1/10,000 ml of infected plasma). The risk estimations for a single
exposure run between 20% and 40% per HBsAg and HBeAg-positive or pre-core
variant subjects and about 6% for contact with blood type HBsAg-positive but HBeAg-
negative and anti-HBe-positive (5, 6).
The annual incidence of infection with HBV among health workers is between
0.5% and 5% (7). In the face of these unfavourable figures we would like to point out
the possibility of an accurate prevention by vaccination and the availability of post-
exposure prophylaxis for non-vaccinated subjects that consists of vaccine and specific
immunoglobulins.
Hepatitis C virus
Hepatitis C virus is now known to cause most cases of what was previously termed
non-A, non-B hepatitis. Most cases of hepatitis C are subclinical, even in the acute
stage. The infection has a much higher rate of chronicity (about 75%) than hepatitis
B. Therefore, it is often uncovered by the serendipitous detection of anti-HCV in
apparently healthy persons (3).
HCV has a high prevalence in general population (2% in Italy) and in some
categories of patients (5.2% in surgical patients, 39.4% in dialysed patients) (8). The
exposure risk is estimated at 1.8% (9, 10). Its resistance to environment and disinfec-
tion is still unknown and neither active nor passive prophylaxis is efficient.
By adopting the EU regulations for safety of health workers exposed to the risk
of transmission of biological agents the Italian government has acknowledged the
problem of occupational infections (11). Beside the legal aspects of the issue, it is
important to recognise the need to evaluate the suitability of a worker for a specific
job which involves exposure to biological agents and to recognise situations which
may determine the course of an occupational or non-occupational infection.
This paper proposes a protocol for risk assessment of infection by HBV and HCV
in personnel occupationally exposed to biological agents and to define criteria for
evaluation of working ability of a health worker infected by HBV and/or HCV.
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SUBJECTS AND METHODS
The study comprised 800 health care professionals in hospital wards involved in
operating procedures, of whom 414 were surgeons, 275 nurses, and 111 anaesthe-
tists (Table 1). The investigation used protocols for monitoring markers of HBV and
HCV infection.
Table 1 Number of health care workers exposed to biological agents by wards
Surgeons Nurses Anaesthetists









Vascular surgery 12 11
Total 414 275 111
We defined a graduated protocol to detect the following markers of HBV infec-
tion using the enzyme-linked immunosorbent assay (ELISA): HBsAg, anti-HBs, anti-
HBc, anti-HBc IgM, HBeAg, and anti-HBe. Molecular hybridisation and polymerase
chain reaction (PCR) were used to detect HBV DNA.
To detect HCV markers, we used the third generation ELISA as a screening test,
the third generation recombinant immunoblot assay (RIBA 3) to confirm the screen-
ing test, and PCR to detect HCV RNA.
First we looked for HBsAg, anti-Hbs, anti-Hbc, and anti-HCV in non-vaccinated
subjects. The results of the markers, considered case by case, served to identify the
necessity for further serologic investigation. Further investigation of HBeAg/anti-HBe
status did not appear necessary in the first stage, but it was important in the evalu-
ation of illness and infectivity of HbsAg-positive subjects. The first step of the second
level of investigation was to search for anti-HBc IgM indicators of viral replication. The
last step of the protocol was to search for HBV DNA using molecular hybridisation,
radiolabeled tube, and PCR (Figure 1).
The first thing to do in the evaluation of risk of HCV infection is to test anti-HCV
with ELISA (Figure 2). Positive results prompt the next step, that is, the investigation
of HCV RNA by PCR, as it indicates the persistence of the virus in the organism. The
application of RIBA 3 that detects antibodies for structural and non-structural anti-
gens of the virus and serves to confirm the infection with HCV is justified only if the
reaction to the anti-HCV test with ELISA can not be clearly interpreted.
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Figure 1 Check-up protocol for the assessment of markers of infection with hepatitis B virus (HBV).
HBsAg – HBV surface antigen (former Australia antigen); anti-HBs – HBV surface antibody;
anti-HBc – HBV core antibody; HBeAg – HBV e antigen; Ig – immunoglobulin; PCR – polymerase
chain reaction; »+« – positive result; »-« – negative result
Figure 2 Check-up protocol for the assessment of markers of infection with hepatitis C virus (HCV).
ELISA – enzyme-linked immunosorbent assay; RIBA 3 – third generation recombinant immunoblot
assay; PCR – polymerase chain reaction; »+« – positive result; »-« – negative result
RESULTS AND DISCUSSION
Positive HBV and/or HCV markers were found in 77 health professionals, that is, nearly
10% of the examined subjects. Fifty-nine were positive to HBV markers of whom 8
HbsAg-positive. Of 13 subjects found to be anti-HCV-positive, 11 were HCV RNA-positive.
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Five persons were found positive to both HBV and HCV. One of them was HbsAg-
positive and one was HCV RNA-positive.
We defined four combinations of antigen-antibody systems to identify groups of
persons with different suitability for a specific job, as follows.
HBsAg-positive, anti-HBc-positive, HBeAg-positive, anti-HBc IgM-positive,
and HBV DNA-positive
This combination reveals acute HBV infection, persistence of viral replication, infectivity
of the blood, and the onset of clinical illness. It is necessary to temporarily remove the
worker from work and to periodically control the markers of HBV infection and activity
of transaminases. In any case, it is necessary that the worker is not exposed to environ-
ments that bear high risk of another infection by HBV or a serious infection by HCV,
HIV, or hepatitis D virus (HDV) such as wards for infectious diseases, gastroenterology,
haemodialysis, and operating rooms for liver transplantation. Furthermore, stress and
heavy physical activities with potential exposure to hepatotoxic agents must be avoided.
HBsAg-positive, anti-HBc-positive, HBeAg-negative, anti-HBe-positive,
anti-HBc IgM-positive, and HBV DNA-positive
This serological pattern shows the appearance of a mutant pre-core variant in the
subjects. It is generally associated with increased enzymatic activity that can be relat-
ed to a serious condition of progressive hepatitis. It is therefore necessary to apply the
same criteria as in the first group.
HBsAg-positive, anti-HBc-positive, HBeAg-negative, anti-Hbe-positive,
anti-HBc IgM-negative, and HBV DNA-negative
This combination in most cases reveals an asymptomatic carrier of the virus. It is
advisable to avoid the risk of another infection as the illness can be exacerbated. The
risk can be prevented by removing a worker from potentially infectious environment
and by avoiding exposure to hepatotoxic agents. This state can persist or can even-
tually disappear with the appearance of anti-HBs, as verified in about 1.5–2% of the
patients. Mutant pre-core with positive HBV DNA findings and elevated transaminases
activity is also possible. Should that be the case, the procedure is to take the same
course as in the two previous groups. In HbsAg-positive patients, it may be required
to determine anti-HDV (total and IgM) and HDV RNA, particularly in the presence of
a clinically overt acute infection or of a significantly increased activity of transaminases.
Anti-HBs-positive, anti-HBc-positive, anti-HBc IgM-negative,
and anti-HBe-positive
This indicates past infection and relative immunity. An anti-HBs-positive patient main-
tains an acquired immunity which is evaluated by determining anti-HBs titre. The
presence of anti-HBc with anti-HBs is not significant beyond indicating previous HBV
infection whereas the presence of anti-HBe points to low infectivity. There are no
contraindications to resuming work.
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The following cases can be taken into consideration if the worker is infected by HCV.
Anti-HCV-positive and HCV RNA-negative (by PCR)
The presence of anti-HCV does not indicate immunisation, but a past contact with
HCV (12). If the pattern appears for the first time it is necessary to check the activity
of transaminases every three months and anti-HCV and HCV RNA (by PCR) every six
to twelve months.
Should the activity of transaminases stabilise at the normal level and HCV RNA
result negative, the subject is clinically considered recovered. While waiting for confir-
mation of recovery, the patient must stay away from a working environment associ-
ated with high risk of infection by the hepatitis virus. Once the work is resumed,
health personnel exposed to biological agents will be required to observe all related
protective measures.
Should, however, elevated activity of transaminases persist regardless of negative
HCV RNA findings, it is necessary to keep the subject under observation for a longer
period and remove her/him from exposure to hepatotoxic agents and potentially in-
fectious environment, as described above.
Anti-HCV-positive and HCV RNA-positive (by PCR)
This denotes persistent condition of viral replication, viremia, and development of a
disease. Beside an extended clinical and laboratory follow-up and likely removal from
work for a certain period, it is necessary for a patient to stay away from environment
bearing high risk of exposure to hepatotoxic agents and to blood-borne pathogens,
especially hepatitis B and C viruses.
*
* *
In conclusion, occupational Health Services in Italy do not to evaluate risk of
transmission of HBV and HCV infection by health care workers to patients. Our data
suggest that screening of hospital personnel exposed to occupational risk of HBV and
HCV infection requires a well-defined protocol based on a graduated evaluation of
markers of HBV and HCV infection. Such protocol may serve in evaluation of the
fitness of infected personnel for a specific job.
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Sa‘etak
KRITERIJI ZA OCJENU SPOSOBNOSTI ZA RAD U ZDRAVSTVENIH
RADNIKA INFICIRANIH VIRUSIMA HEPATITISA B I C
U priop}enju je predlo‘en stupnjevani protokol za procjenu pokazatelja infekcije virusom hepatitisa B (HBV) i
virusom hepatitisa C (HCV) u profesionalno izlo‘enih zdravstvenih radnika kao i za utvr|ivanje kriterija za ocjenu
sposobnosti za rad inficiranog osoblja. U istra‘ivanju je obuhva}eno 800 zdravstvenih radnika koji sudjeluju u
operativnim zahvatima: 414 kirurga, 275 medicinskih sestara i 111 anesteziologa.
Prema definiranim kombinacijama ispitivanih pokazatelja u sustavima antigen-antitijelo, ispitanici inficirani virusom
hepatitisa B razvrstani su u ~etiri skupine s razli~itom sposobno{}u za rad, prema ovim nalazima:
1) HBsAg pozitivan, HBeAg pozitivan, HBV DNK pozitivan;
2) HBsAg pozitivan, anti-HBe pozitivan, HBV DNK pozitivan;
3) HBsAg pozitivan, anti-HBe pozitivan, HBV DNK negativan;
4) anti-HBs pozitivan, anti-HBc pozitivan, anti-HBe pozitivan.
Sli~no su razvrstane osobe inficirane virusom hepatitisa C u dvije skupine, prema ovim nalazima:
1) anti-HCV pozitivan, HCV RNK negativan;
2) anti-HCV pozitivan, HCV RNK pozitivan.
Zaklju~eno je da, budu}i da u Italiji Slu‘ba medicine rada nema u nadle‘nosti nadzor medicinskog osoblja koje je u
pove}anom riziku od infekcije HBV-om i HCV-om, valja usvojiti jasno definirani protokol za utvr|ivanje pokazatelja
infekcije u profesionalno izlo‘enih osoba. Takav protokol mogao bi poslu‘iti za dono{enje kriterija za ocjenu
sposobnosti za rad inficiranog osoblja.
Klju~ne rije~i:
pokazatelji infekcije, profesionalna izlo‘enost, stupnjevani protokol, sustavi antigen-antitijelo
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